Roivant Sciences (NASDAQ:ROIV) is gearing up to announce its quarterly earnings on Friday, 2026-02-06. Here’s a quick overview of what investors should know before the release.
Analysts are estimating that Roivant Sciences will report an earnings per share (EPS) of $-0.34.
Roivant Sciences bulls will hope to hear the company announce they’ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
Past Earnings Performance
During the last quarter, the company reported an EPS beat by $0.04, leading to a 1.28% drop in the share price on the subsequent day.
Here’s a look at Roivant Sciences’s past performance and the resulting price change:
| Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 |
|---|---|---|---|---|
| EPS Estimate | -0.32 | -0.26 | -0.16 | -0.24 |
| EPS Actual | -0.28 | -0.25 | -0.22 | -0.20 |
| Price Change % | -1.00 | 4.00 | -3.00 | -3.00 |
Market Performance of Roivant Sciences’s Stock
Shares of Roivant Sciences were trading at $21.65 as of February 03. Over the last 52-week period, shares are up 98.81%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.
Analyst Insights on Roivant Sciences
For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on Roivant Sciences.
Analysts have given Roivant Sciences a total …